X0306 4 2014-06-12 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001384243 Quart Barry D 33 HAYDEN AVE LEXINGTON MA 02421 true false false false Common Stock 2014-06-12 4 M false 1000 23 A 1000 D Common Stock 2014-06-12 4 S false 1000 83.31 D 0 D Stock Option (Right to Buy) 23 2014-06-12 4 M false 1000 0 D 2021-12-20 Common Stock 1000 8375 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014. The reporting person previously transferred an option to purchase 5,625 Shares of the original 15,000 granted under this stock option, which transfer was not reported as permitted under Rule 16a-12 of the Securities Exchange Act. The stock option granted the reporting person an option to purchase 15,000 Shares. 1/36 of such Shares vested and became exercisable on 12/02/2011, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $83.30 to $83.33. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. /s/ Stephen F. Mahoney, Attorney-in-Fact 2014-06-16